sunitinib malate (Sutent)

DRUG2 trials

Sponsors

Icahn School of Medicine at Mount Sinai, University Health Network, Toronto

Conditions

CancerRenal Cell Carcinoma

Phase 1

Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

CompletedNCT00463060

Icahn School of Medicine at Mount SinaiCancer

Start: 2007-01-31End: 2014-07-31Updated: 2018-07-18

Phase 2

A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma

TerminatedNCT00480935

University Health Network, TorontoRenal Cell Carcinoma

Start: 2007-10-31End: 2011-10-31Updated: 2015-12-09

Related Papers

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

2012-06-2757 citations